Chair: M. Böhm (Homburg/Saar), S. Frantz (Würzburg), S. von Haehling (Göttingen)
|
In Case of Overcrowding: Overflow Area Saal 12 (Dorint Hotel) |
||
| 15:30 | (V166) | Introduction |
| M. Böhm (Homburg/Saar) | ||
| 15:35 | (V167) | Most critical changes in pharmacological management in systolic heart failure in 2022 |
| M. Böhm (Homburg/Saar) | ||
| 15:50 | Diskussion | |
| 15:55 | (V168) | Role of the right heart in heart failure |
| S. Rosenkranz (Köln) | ||
| 16:10 | Diskussion | |
| 16:15 | (V169) | Therapeutic algorithms in patients with HFrEF and valvular disease |
| N. Karam (München) | ||
| 16:30 | Diskussion | |
| 16:35 | (V170) | End stage heart failure – What should be offered when? |
| A. Mebazaa (Paris, FR) | ||
| 16:50 | Diskussion | |
| 16:55 | (V171) | Conclusion |
| S. von Haehling (Göttingen) |
